Effectiveness of population‐based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: Socioeconomic status, parity, and age at birth of first child

Invitation to mammography screening of women aged 40 to 49 years is a matter of debate in many countries and a cost‐effective alternative in countries without screening among women aged 40 to 49 years could be inviting those at higher risk. The relative effectiveness of mammography screening was estimated for subgroups based on the breast cancer risk factors parity, age at time of birth of first child, and socioeconomic status (SES).

[1]  M. Cowles Statistical Computing: An Introduction to Data Analysis using SPlus , 2004 .

[2]  G. Fagerberg,et al.  Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. , 1995, Acta oncologica.

[3]  Eiliv Lund,et al.  Education and risk of breast cancer in the Norwegian‐Swedish women's lifestyle and health cohort study , 2004, International journal of cancer.

[4]  H. D. de Koning,et al.  Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years , 2012, Annals of Internal Medicine.

[5]  G. Colditz Epidemiology and Prevention of Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[6]  Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: A comparative modeling study of risk: Editorial Comment , 2012 .

[7]  S. Duffy,et al.  Age at first birth, parity and risk of breast cancer: A meta‐analysis of 8 studies from the nordic countries , 1990, International journal of cancer.

[8]  E. Grundy,et al.  Fertility history and cause-specific mortality: a register-based analysis of complete cohorts of Norwegian women and men. , 2010, Social science & medicine.

[9]  A. Tjønneland,et al.  Social inequality and incidence of and survival from breast cancer in a population-based study in Denmark, 1994-2003. , 2008, European journal of cancer.

[10]  Longitudinal data for interdisciplinary ageing research. Design of the Linnaeus Database , 2010, Scandinavian journal of public health.

[11]  R Holland,et al.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of Oncology.

[12]  Consumer Protection,et al.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  V. Beral,et al.  Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis , 2009, British Journal of Cancer.

[14]  K. Hemminki,et al.  Socio-economic status and overall and cause-specific mortality in Sweden , 2008, BMC public health.

[15]  E. Grundy,et al.  Socioeconomic inequalities in mortality rates in old age in the World Health Organization Europe region. , 2013, Epidemiologic reviews.

[16]  P. Karlsson,et al.  Long-term inequalities in breast cancer survival – a ten year follow-up study of patients managed within a National Health Care System (Sweden) , 2008, Acta oncologica.

[17]  H. Vandenheede,et al.  Does birth history account for educational differences in breast cancer mortality? A comparison of premenopausal and postmenopausal women in Belgium , 2012, International journal of cancer.

[18]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[19]  G. Landberg,et al.  Parity in relation to survival following breast cancer. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[21]  N Segnan,et al.  Adjusting for non-compliance and contamination in randomized clinical trials. , 1997, Statistics in medicine.

[22]  T. Wilt,et al.  Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2011 .

[23]  Roger A Forsyth,et al.  Treatment of pituitary neoplasms with temozolomide , 2011, Cancer.

[24]  S. Tretli,et al.  Weak associations between sociodemographic factors and breast cancer: possible effects of early detection , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[25]  J. Mackenbach,et al.  Socioeconomic inequalities in health in 22 European countries. , 2008, The New England journal of medicine.